Product correctly added to cart.

discount label
Sch-202676 hydrobromide
View 3D

Biosynth logo

Sch-202676 hydrobromide

CAS: 265980-25-4

Ref. 3D-QKA98025

10mg
216.00 €
100mg
860.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025

Product Information

Name:
Sch-202676 hydrobromide
Description:

Sch-202676 hydrobromide is a drug that belongs to the class of allosteric modulators. It has been shown to inhibit the proliferation of pluripotent stem cells and tumor cells in combination with ionomycin, an activator of Ca2+ channels. This drug also sensitizes cancer cells to other pathway inhibitors such as temozolomide, an alkylating agent. Sch-202676 hydrobromide inhibits the production of reactive oxygen species (ROS) by inhibiting nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which is a key enzyme in ROS production. Sch-202676 hydrobromide has been shown to induce sclerosis in mice by blocking intracellular signaling pathways that activate the transcriptional regulator p38 mitogen-activated protein kinase (MAPK). This leads to hyperactivity and increased cell death in neurons.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
348.3 g/mol
Formula:
C15H14BrN3S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-QKA98025 Sch-202676 hydrobromide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".